Pregled bibliografske jedinice broj: 1247273
Komorbiditet shizofrenije i Parkinsonove bolesti - Prikaz slučaja
Komorbiditet shizofrenije i Parkinsonove bolesti - Prikaz slučaja // MIND & BRAIN 60th INTERNATIONAL NEUROPSYCHIATRIC CONGRESS Virtual MAY 27th – 30th, 2021. ISSN 2459-5748 / Demarin, Vida ; Budinčević, Hrvoje (ur.).
Zagreb: International Institute for Brain Health, 2021. str. 70-70 (poster, nije recenziran, sažetak, ostalo)
CROSBI ID: 1247273 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Komorbiditet shizofrenije i Parkinsonove bolesti - Prikaz slučaja
(Comorbiditiy Of Schizophrenia And Parkinson's Disease - Case Report)
Autori
Vlatković, Suzana ; Bilić, Petar ; Živković, Maja ; Perušić, Darko ; Bektić Hodžić, Jasminka ; Ćelić, Ivan ; Brečić, Petrana
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, ostalo
Izvornik
MIND & BRAIN 60th INTERNATIONAL NEUROPSYCHIATRIC CONGRESS Virtual MAY 27th – 30th, 2021. ISSN 2459-5748
/ Demarin, Vida ; Budinčević, Hrvoje - Zagreb : International Institute for Brain Health, 2021, 70-70
Skup
60. Međunarodni neuropsihijatrijski kongres (MIND & BRAIN)
Mjesto i datum
Pula, Hrvatska, 27.05.2021. - 31.05.2021
Vrsta sudjelovanja
Poster
Vrsta recenzije
Nije recenziran
Ključne riječi
Shizofrenija ; Komorbiditet ; Parkinsonova bolest
(Schizophrenia ; Comorbidity ; Parkinson's disease)
Sažetak
Comorbidity is one of the most significant challenges in diagnostic and therapeutic procedures in clinical medicine, but also in scientific research and nosology. The occurrence of comorbidity that is secondary syndrome or disease raises the question of whether it is an accidental phenomenon, whether there may be a causal relationship with the primary disorder or whether it is simply synchronicity. Schizophrenia and Parkinson's disease are progressive and degenerative diseases of the central nervous system with overlapping neurobiological etiopathogenesis of dopaminergic system disorders. In schizophrenia, symptoms appear depending on the hypo or hyperactivity of dopamine, while in Parkinson's disease the syndrome is caused by hypodopaminergia. Regardless of early recognition, personalized treatment and duration of both diseases, the treatment outcome is very unfavorable due to the irreversible death of nerve cells of the dopaminergic system.
Izvorni jezik
Hrvatski
POVEZANOST RADA
Profili:
Petar Bilić
(autor)
Suzana Vlatković
(autor)
Ivan Ćelić
(autor)
Maja Živković
(autor)
Petrana Brečić
(autor)